- Additional Proxy Soliciting Materials (definitive) (DEFA14A)
June 18 2010 - 2:52PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule
14a-101)
SCHEDULE
14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities
Exchange Act of 1934
Filed by the Registrant
þ
Filed by a Party other than the Registrant
o
Check the appropriate box:
o
|
|
Preliminary Proxy Statement
|
o
|
|
Confidential, For Use of the Commission Only (as permitted by Rule 14a-
6(e)(2)
)
|
o
|
|
Definitive Proxy Statement
|
o
|
|
Definitive Additional Materials
|
þ
|
|
Soliciting Material Pursuant to §240.14a-12
|
ODYSSEY HEALTHCARE, INC.
(Name of Registrant as Specified in Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
þ
|
|
No fee required.
|
o
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act
Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was
determined):
|
|
|
|
|
|
|
|
|
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
|
|
|
|
|
|
|
|
|
(5)
|
|
Total fee paid:
|
|
|
|
|
|
|
|
|
|
o
|
|
Fee paid previously with preliminary materials:
|
|
o
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2)
and identify the filing for which the offsetting fee was paid previously. Identify the
previous filing by registration statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
|
Amount previously paid:
|
|
|
|
|
|
|
|
|
|
|
|
(2)
|
|
Form, Schedule or Registration statement no.:
|
|
|
|
|
|
|
|
|
|
|
|
(3)
|
|
Filing Party:
|
|
|
|
|
|
|
|
|
|
|
|
(4)
|
|
Date Filed:
|
|
|
|
|
|
|
|
|
|
On June 18, 2010, the following article appeared in the June edition of the employee
newsletter of Odyssey HealthCare, Inc.:
Two Great Names; One Important Mission
On May 24, Odyssey entered into an agreement to be acquired by Gentiva Health Services, a
leading home healthcare provider, based in Atlanta. Gentiva, which also has a relatively small
hospice operation, wanted to expand its hospice presence, said Bob Lefton, Odysseys President and
Chief Executive Officer. They chose Odyssey because they believe were the nations premier
hospice provider, he said. Were excited about this transaction, as it brings together two
complementary businesses and positions the combined company for leadership in the hospice
industry, he added.
The combined average daily hospice census will be approximately 14,000, with operations in 30
states and $1.8 billion in revenue. We anticipate the combination of the two companies will
create the largest U.S. healthcare provider focused on home health and hospice services, Lefton
said.
Gentiva has more than 9,000 employees and provides home healthcare services to over 350,000
patients in 350 community locations. Being part of a larger, more diversified organization will
create opportunities for our employees and more options to better serve our patients, said Lefton.
Gentiva also shares our commitment for compassionate, personalized care of patients and their
families, he added.
We believe this decision is the best one for the company and its future, Lefton stated. It
accelerates our vision of becoming the premier, most successful provider of end-of-life care in the
United States. It also strengthens our ability to face the challenges that lie ahead as we
continue to deal with lower reimbursement issues.
Lefton noted that the transaction is expected to close in the third quarter of this year, after
receiving customary approvals, including that of Odyssey stockholders. Until then, we will
continue to operate as separate companies, he said. With that in mind, its important that we
remain focused on our day-to-day responsibilities and continue to meet the needs of our patients
and their families.
Lefton said minimal changes are anticipated in the companys field operations. But we are
committed to keeping our team members informed and regular updates will be provided throughout the
course of this process, he said.
-2-
Gentiva at a Glance
Corporate headquarters: Atlanta
Employees: 9,000
Patients: 350,000
Community Locations: 350
President & CEO: Tony Strange
Additional Information
Odyssey filed a preliminary proxy statement with the Securities and Exchange Commission (the SEC)
on June 11, 2010 and intends to file a definitive proxy statement and other relevant materials in
connection with the acquisition. The definitive proxy statement will be sent or given to the
stockholders of Odyssey. Before making any voting or investment decision with respect to the
acquisition, investors and stockholders of Odyssey are urged to read the proxy statement and the
other relevant materials when they become available because they will contain important information
about the acquisition. The proxy statement and other relevant materials (when they become
available), and any other documents filed by Odyssey with the SEC, may be obtained free of charge
from Odyssey by directing a request to Odysseys Investor Relations Department at toll free phone
number 888-922-9711, email address InvestorRelations@odsyhealth.com or through the Company Web site
www.odsyhealth.com under Investor Relations InfoRequest.
Participants in the Solicitation
Odyssey and its directors and executive officers may be deemed to be participants in the
solicitation of proxies from Odyssey stockholders in connection with the merger. Information about
Odysseys directors and executive officers is set forth in Odysseys proxy statement on Schedule
14A filed with the SEC on April 5, 2010 and Odysseys Annual Report on Form 10-K filed on March 10,
2010. Additional information regarding the interests of participants in the solicitation of proxies
in connection with the merger will be included in the proxy statement that Odyssey intends to file
with the SEC.
-3-
Forward-looking Statements
Certain statements contained in this filing are forward-looking statements within the meaning of
the federal securities laws. Such forward-looking statements are based on managements current
expectations and are subject to known and unknown risks, uncertainties and assumptions which may
cause the forward-looking events and circumstances discussed in this filing to differ materially
from those anticipated or implied by the forward-looking statements. Such risks, uncertainties and
assumptions include, but are not limited to, the ability to obtain regulatory approval for the
transaction; the expected timing of the completion of the transaction; management plans regarding
the transaction; the inability to complete the transaction due to the failure to satisfy the
conditions required to complete the transaction; the risk that the businesses of Odyssey and
Gentiva will not be integrated successfully, or will take longer than anticipated; the risk that
expected cost savings from the transaction will not be achieved or unexpected costs will be
incurred; any statements of the plan, strategies and objectives of management for future
operations; the risk that employee, referral source and patient retention goals will not be met and
that disruptions from the transaction will harm relationships with employees, referral sources,
patients and suppliers; the outcome of litigation and regulatory proceedings to which we may be a
party; actions of competitors; changes and developments
affecting our industry; quarterly or cyclical variations in
financial results; interest rates and cost of borrowing; any statements of expectation or belief; and other risk factors as set forth
from time to time in Odysseys filings with the Securities and Exchange Commission. Many of these
factors are beyond our ability to control or predict. Given these uncertainties, readers are
cautioned not to place undue reliance on such forward-looking statements, which reflect
managements views only as of the date hereof. We undertake no obligation to revise or update any
of the forward-looking statements or publicly announce any updates or revisions to any of the
forward-looking statements contained herein to reflect any change in our expectations with regard
thereto or any change in events, conditions, circumstances or assumptions underlying such
statements.
-4-
Odyssey Healthcare (MM) (NASDAQ:ODSY)
Historical Stock Chart
From Apr 2024 to May 2024
Odyssey Healthcare (MM) (NASDAQ:ODSY)
Historical Stock Chart
From May 2023 to May 2024